Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | CRWV | COREWEAVE INC | Technology | 2,892.0 | $224K | 0.08% | NEW | — | $77.47 | +17.0% |
| 182 | EDU | NEW ORIENTAL ED & TECHNOLOGY | Consumer Defensive | 3,956.0 | $224K | 0.08% | -8K | -66.5% | $56.63 | -0.4% |
| 183 | PHVS | PHARVARIS N V | Healthcare | 7,904.0 | $223K | 0.08% | NEW | — | $28.25 | +23.6% |
| 184 | — | SEADRILL LTD | — | 4,961.0 | $223K | 0.08% | NEW | — | $44.95 | — |
| 185 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 46,644.0 | $223K | 0.08% | -464.0 | -1.0% | $4.78 | +27.0% |
| 186 | AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | 17,808.0 | $221K | 0.08% | NEW | — | $12.43 | +45.9% |
| 187 | EQ | EQUILLIUM INC | Healthcare | 110,117.0 | $220K | 0.08% | +17K | +18.2% | $2.00 | +5.5% |
| 188 | — | PASITHEA THERAPEUTICS CORP | — | 290,555.0 | $216K | 0.08% | — | — | $0.74 | — |
| 189 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 16,525.0 | $209K | 0.08% | -941.0 | -5.4% | $12.63 | +9.0% |
| 190 | — | SURROZEN INC | — | 7,143.0 | $208K | 0.08% | +3K | +63.9% | $29.13 | — |
| 191 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 35,661.0 | $207K | 0.08% | -10K | -21.8% | $5.80 | +36.7% |
| 192 | — | SOLID BIOSCIENCES INC | — | 27,990.0 | $202K | 0.07% | NEW | — | $7.20 | — |
| 193 | LNTH | LANTHEUS HLDGS INC | Healthcare | 2,642.0 | $200K | 0.07% | NEW | — | $75.85 | +33.1% |
| 194 | CYTK CALL | CYTOKINETICS INC | Healthcare | 231.0 | $197K | 0.07% | NEW | — | $853.00 | -91.0% |
| 195 | — | BENITEC BIOPHARMA INC | — | 18,307.0 | $195K | 0.07% | -2K | -11.8% | $10.65 | — |
| 196 | REPL | REPLIMUNE GROUP INC | Healthcare | 25,445.0 | $195K | 0.07% | -36K | -58.6% | $7.65 | +57.6% |
| 197 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 42,124.0 | $190K | 0.07% | NEW | — | $4.50 | -7.6% |
| 198 | CAPR PUT | CAPRICOR THERAPEUTICS INC | Healthcare | 1,578.0 | $188K | 0.07% | NEW | — | $119.39 | -96.6% |
| 199 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 8,108.0 | $187K | 0.07% | +145.0 | +1.8% | $23.07 | +33.7% |
| 200 | ANNX | ANNEXON INC | Healthcare | 33,625.0 | $186K | 0.07% | -60K | -64.1% | $5.54 | -2.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
50.0%
Healthcare
30.0%
Financial Services
9.1%
Consumer Cyclical
3.4%
Energy
2.7%
Basic Materials
2.1%
Communication Services
1.9%
Industrials
0.4%
Consumer Defensive
0.3%